CY1107415T1 - Φαρμακευτικη συνθεση η οποια συνδυαζει τενατοπροζολη και εναν ανταγωνιστη των υποδοχεων h2 της ισταμινης - Google Patents
Φαρμακευτικη συνθεση η οποια συνδυαζει τενατοπροζολη και εναν ανταγωνιστη των υποδοχεων h2 της ισταμινηςInfo
- Publication number
- CY1107415T1 CY1107415T1 CY20081100445T CY081100445T CY1107415T1 CY 1107415 T1 CY1107415 T1 CY 1107415T1 CY 20081100445 T CY20081100445 T CY 20081100445T CY 081100445 T CY081100445 T CY 081100445T CY 1107415 T1 CY1107415 T1 CY 1107415T1
- Authority
- CY
- Cyprus
- Prior art keywords
- tenatoprozol
- histamin
- competent
- receptors
- combines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεση αφορά ένα νέο φαρμακευτικό συνδυασμό. Η φαρμακευτική σύνθεση, για την αγωγή παθήσεων συνδεόμενων με τη στομαχική υπεροξύτητα, περιλαμβάνει σε συνδυασμό τενατοπραζόλη και έναν ή περισσότερους ανταγωνιστές των υποδοχέων Η2 της ισταμίνης επιλεγόμενους από την κιμετιδίνη, τη ρανιτιδίνη, τη φαμοτιδίνη και τη νιζατιδίνη. Εφαρμογή ειδικά στην αγωγή ελκών του στομάχου και του δωδεκαδάκτυλου και των συμπτωμάτων και κακώσεων της γαστρο-οισοφαγικής αναρροής.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0213114A FR2845916B1 (fr) | 2002-10-21 | 2002-10-21 | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine |
EP03778429A EP1553944B1 (fr) | 2002-10-21 | 2003-10-21 | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l histamine |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107415T1 true CY1107415T1 (el) | 2012-12-19 |
Family
ID=32050604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100445T CY1107415T1 (el) | 2002-10-21 | 2008-04-21 | Φαρμακευτικη συνθεση η οποια συνδυαζει τενατοπροζολη και εναν ανταγωνιστη των υποδοχεων h2 της ισταμινης |
Country Status (18)
Country | Link |
---|---|
US (2) | US20060241136A1 (el) |
EP (1) | EP1553944B1 (el) |
JP (1) | JP5303093B2 (el) |
KR (1) | KR101153571B1 (el) |
CN (1) | CN1744896B (el) |
AT (1) | ATE387201T1 (el) |
AU (1) | AU2003285428A1 (el) |
BR (1) | BR0315445A (el) |
CA (1) | CA2503215C (el) |
CY (1) | CY1107415T1 (el) |
DE (1) | DE60319399T2 (el) |
DK (1) | DK1553944T3 (el) |
ES (1) | ES2299738T3 (el) |
FR (1) | FR2845916B1 (el) |
IL (1) | IL167590A (el) |
PT (1) | PT1553944E (el) |
SI (1) | SI1553944T1 (el) |
WO (1) | WO2004037256A1 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2845915B1 (fr) * | 2002-10-21 | 2006-06-23 | Negma Gild | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
FR2848555B1 (fr) * | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
WO2006043280A1 (en) * | 2004-10-19 | 2006-04-27 | Council Of Scientific And Industrial Research | Tenatoprazole salts and process of preparation thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0643426B2 (ja) * | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
US5714505A (en) * | 1994-01-05 | 1998-02-03 | Astra Aktiebolag | Method for treatment of psoriasis, by omeprazole or related compounds |
US6362202B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
SE9903831D0 (sv) * | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
US8206741B2 (en) * | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
FR2845915B1 (fr) * | 2002-10-21 | 2006-06-23 | Negma Gild | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
FR2848555B1 (fr) * | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
-
2002
- 2002-10-21 FR FR0213114A patent/FR2845916B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-21 EP EP03778429A patent/EP1553944B1/fr not_active Expired - Lifetime
- 2003-10-21 AT AT03778429T patent/ATE387201T1/de active
- 2003-10-21 PT PT03778429T patent/PT1553944E/pt unknown
- 2003-10-21 BR BR0315445-9A patent/BR0315445A/pt not_active IP Right Cessation
- 2003-10-21 DE DE60319399T patent/DE60319399T2/de not_active Expired - Lifetime
- 2003-10-21 SI SI200331135T patent/SI1553944T1/sl unknown
- 2003-10-21 AU AU2003285428A patent/AU2003285428A1/en not_active Abandoned
- 2003-10-21 CA CA2503215A patent/CA2503215C/fr not_active Expired - Fee Related
- 2003-10-21 CN CN2003801072007A patent/CN1744896B/zh not_active Expired - Fee Related
- 2003-10-21 JP JP2004546116A patent/JP5303093B2/ja not_active Expired - Fee Related
- 2003-10-21 WO PCT/FR2003/003124 patent/WO2004037256A1/fr active IP Right Grant
- 2003-10-21 KR KR1020057006843A patent/KR101153571B1/ko not_active IP Right Cessation
- 2003-10-21 ES ES03778429T patent/ES2299738T3/es not_active Expired - Lifetime
- 2003-10-21 US US10/532,114 patent/US20060241136A1/en not_active Abandoned
- 2003-10-21 DK DK03778429T patent/DK1553944T3/da active
-
2005
- 2005-03-22 IL IL167590A patent/IL167590A/en not_active IP Right Cessation
-
2008
- 2008-04-21 CY CY20081100445T patent/CY1107415T1/el unknown
-
2011
- 2011-11-15 US US13/297,122 patent/US20120122919A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR101153571B1 (ko) | 2012-06-11 |
CN1744896B (zh) | 2011-08-31 |
DK1553944T3 (da) | 2008-06-23 |
DE60319399T2 (de) | 2009-02-19 |
PT1553944E (pt) | 2008-03-31 |
CA2503215A1 (fr) | 2004-05-06 |
AU2003285428A8 (en) | 2004-05-13 |
CN1744896A (zh) | 2006-03-08 |
AU2003285428A1 (en) | 2004-05-13 |
ATE387201T1 (de) | 2008-03-15 |
EP1553944B1 (fr) | 2008-02-27 |
EP1553944A1 (fr) | 2005-07-20 |
BR0315445A (pt) | 2005-08-16 |
DE60319399D1 (de) | 2008-04-10 |
CA2503215C (fr) | 2012-02-21 |
US20060241136A1 (en) | 2006-10-26 |
FR2845916A1 (fr) | 2004-04-23 |
WO2004037256A1 (fr) | 2004-05-06 |
US20120122919A1 (en) | 2012-05-17 |
ES2299738T3 (es) | 2008-06-01 |
JP2006506377A (ja) | 2006-02-23 |
IL167590A (en) | 2009-05-04 |
FR2845916B1 (fr) | 2006-07-07 |
SI1553944T1 (sl) | 2008-12-31 |
JP5303093B2 (ja) | 2013-10-02 |
KR20050098831A (ko) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS51672B (en) | FLUOROSubstituted Cycloalkanoindoles and Their Use as Prostaglandin D2 Receptor Antagonists | |
NO20041504L (no) | Lactamderivater som antagonister for humane 11CBY reseptorer. | |
CY1107878T1 (el) | Διεργασια για την παραγωγη της βαλσαρτανης | |
DK1501809T3 (da) | Trizolderivater som tachykininreceptorantagonister | |
DK1571145T3 (da) | Substitueret piperidinforbindelser til anvendelse som H3 histaminreceptor-antagonister | |
CY1108539T1 (el) | Ανταγωνιστες υποδοχεα ταχυκινινης | |
DK1224175T3 (da) | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister | |
NO20031474D0 (no) | Metabotropiske glutamatreseptorantagonister | |
CY1107415T1 (el) | Φαρμακευτικη συνθεση η οποια συνδυαζει τενατοπροζολη και εναν ανταγωνιστη των υποδοχεων h2 της ισταμινης | |
NO20060195L (no) | Kinolylamidderivater som CCR-5-antagonister | |
NO20044666L (no) | (Imidazol-1-yl-metyl)-pyridazin som NMDA-reseptor-blokker | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
DE60302157D1 (de) | Opioidrezeptorantagonisten | |
CY1107681T1 (el) | Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων | |
DK1636206T3 (da) | Imidazolderivater som glutamatreceptorantagonister | |
NO20055758D0 (no) | Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister | |
CY1108495T1 (el) | Μη στεροειδεις ρυθμιστες υποδοχεων προγεστερονης | |
NO20044373L (no) | Azetidinderivater som CCR-3-reseptorantagonister | |
WO2005040157A3 (en) | Novel mch receptor antagonists | |
HRP20050898A2 (en) | Glutamate receptor antagonists as neuroprotectives | |
DK1558259T3 (da) | Ureaderivater som IL-8 -receptorantagonister | |
ECSP034708A (es) | Nueva sal de benzoilguanidina | |
AU2003274087A1 (en) | Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor | |
TW200519117A (en) | Crystal of sufoxide derivatives -HC1 | |
TH67340A (th) | ตัวต้านตัวรับกรดอะมิโนเร้า |